Clinical trial · Observational
A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver Genes
A Prospective Observational Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Driver Genes
NCT03710629CI-TRIAL-00035363unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A single-center, non-interventional prospective observational study in the NSCLC patients with different driver genes
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patients with driver genes | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- NSCLC patients with driver genes
- description
- NSCLC patients and driver genes
- interventionNames
- Other: Patients with driver genes
Primary outcomes (1)
- measure
- Differences in overall survival rates
- timeFrame
- 2018-2022
- description
- Differences in overall survival rates of the NSCLC patients with various gene types
Secondary outcomes (7)
- measure
- Interaction impact between gene types and treatment modalities or regimens on disease-free survivals
- timeFrame
- 2018-2022
- description
- Interaction impact between gene types and treatment modalities or regimens on disease-free survivals
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * The patients with lung cancer who were performed with next-generation sequencing (NGS) technology from 2015 to 2017; * The patients who were at least 18 years; * The pathologically diagnosed patients with non-small cell lung cancer (NSCLC) Exclusion Criteria: -None
References
Publications (0)
Data not yet available
No reference posted for this study.